Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Market Analysis & Valuation

UpdatedApr 20, 2026
DataAggregated Company Financials
Companies205
  • 7D2.0%
  • 3M2.0%
  • 1Y15.6%
  • YTD2.0%

The market has climbed 2.0% in the last 7 days, lead by the Industrials sector with a gain of 4.6%. As for the past 12 months, the market is up 16%. Looking forward, earnings are forecast to grow by 10% annually.

Market Valuation and Performance

Has the Swiss Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 20 Apr 2026CHF 2.0tCHF 777.6bCHF 109.3b21.2x18.5x2.6x
Wed, 18 Mar 2026CHF 1.9tCHF 777.8bCHF 109.1b20x17.7x2.5x
Fri, 13 Feb 2026CHF 2.0tCHF 787.8bCHF 117.5b20.5x17.2x2.6x
Sun, 11 Jan 2026CHF 2.0tCHF 799.5bCHF 115.2b20.5x17.6x2.5x
Tue, 09 Dec 2025CHF 1.9tCHF 802.2bCHF 114.9b19.3x16.9x2.4x
Thu, 06 Nov 2025CHF 1.9tCHF 802.5bCHF 114.6b19.2x16.3x2.3x
Sat, 04 Oct 2025CHF 1.9tCHF 774.1bCHF 90.3b19.6x20.9x2.4x
Mon, 01 Sep 2025CHF 1.9tCHF 775.5bCHF 90.1b19.9x20.6x2.4x
Wed, 30 Jul 2025CHF 1.8tCHF 795.3bCHF 108.6b20.6x16.9x2.3x
Fri, 27 Jun 2025CHF 1.8tCHF 785.8bCHF 106.8b20.1x16.7x2.3x
Sun, 25 May 2025CHF 1.8tCHF 785.0bCHF 106.4b20.1x17.1x2.3x
Tue, 22 Apr 2025CHF 1.7tCHF 832.4bCHF 156.8b18.6x10.9x2.1x
Thu, 20 Mar 2025CHF 1.9tCHF 849.3bCHF 158.6b20x12.1x2.3x
Sat, 15 Feb 2025CHF 1.9tCHF 820.2bCHF 116.4b22.2x16.4x2.3x
Mon, 13 Jan 2025CHF 1.8tCHF 820.2bCHF 118.0b20.8x15x2.2x
Wed, 11 Dec 2024CHF 1.7tCHF 809.4bCHF 117.0b20.7x14.9x2.2x
Fri, 08 Nov 2024CHF 1.8tCHF 812.1bCHF 117.5b20.2x15.1x2.2x
Sun, 06 Oct 2024CHF 1.8tCHF 804.5bCHF 114.1b21.3x15.8x2.2x
Tue, 03 Sep 2024CHF 1.9tCHF 801.8bCHF 113.8b21.8x16.3x2.3x
Thu, 01 Aug 2024CHF 1.8tCHF 793.4bCHF 125.6b21.9x14.7x2.3x
Sat, 29 Jun 2024CHF 1.8tCHF 801.3bCHF 125.7b21.1x14.3x2.2x
Mon, 27 May 2024CHF 1.8tCHF 808.4bCHF 126.7b21.7x14.2x2.2x
Wed, 24 Apr 2024CHF 1.7tCHF 770.5bCHF 97.2b21.5x17.9x2.3x
Fri, 22 Mar 2024CHF 1.8tCHF 766.7bCHF 98.2b21.3x18.1x2.3x
Sun, 18 Feb 2024CHF 1.7tCHF 769.0bCHF 109.6b19.6x15.7x2.2x
Tue, 16 Jan 2024CHF 1.7tCHF 762.8bCHF 109.7b18.2x15.3x2.2x
Thu, 14 Dec 2023CHF 1.7tCHF 768.6bCHF 110.8b18.6x15.2x2.2x
Sat, 11 Nov 2023CHF 1.6tCHF 776.2bCHF 112.2b17.5x14.2x2.1x
Mon, 09 Oct 2023CHF 1.6tCHF 764.2bCHF 100.7b18.1x16.2x2.1x
Wed, 06 Sep 2023CHF 1.7tCHF 748.3bCHF 98.9b18.8x16.8x2.2x
Fri, 04 Aug 2023CHF 1.7tCHF 741.8bCHF 76.3b18.3x22x2.3x
Sun, 02 Jul 2023CHF 1.7tCHF 757.2bCHF 76.9b19.5x22.4x2.3x
Tue, 30 May 2023CHF 1.8tCHF 787.2bCHF 82.7b19.1x21.2x2.2x
Thu, 27 Apr 2023CHF 1.8tCHF 788.7bCHF 81.1b19.6x21.6x2.2x
Price to Earnings Ratio

21.6x


Total Market Cap: CHF 1.8tTotal Earnings: CHF 81.1bTotal Revenue: CHF 788.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Market Price to Earnings3Y Average 16.9x202420252026
Current Market PE
  • Investors are relatively neutral on the Swiss market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading close to its 3-year average PE ratio of 16.9x.
Past Earnings Growth
  • The earnings for Swiss listed companies have grown 10% per year over the last three years, while revenues have remained steady.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Sector Trends

Which sectors have driven the changes within the Swiss Market?

CH Market2.01%
Tech10.67%
Materials4.72%
Industrials4.61%
Consumer Discretionary4.08%
Financials1.79%
Healthcare0.66%
Consumer Staples0.47%
Real Estate-0.13%
Utilities-1.13%
Telecom-1.50%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading above its 3-year average PE ratio of 29.4x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 20.0% which is higher than its past year's earnings decline of 30.9% per year.
  • The Financials sector is the least preferred by investors for future growth. Although, investor sentiment seems to have improved given that it's trading above its 3-year average of 7.3x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings decline of 31% per year.
  • In contrast, the Real Estate sector is expected to see its earnings decline by 6.6% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
ABBN ABBCHF 75.485.4%
+CHF 7.1b		78.9%PE38.4xIndustrials
UBSG UBS GroupCHF 34.454.2%
+CHF 4.3b		49.8%PE17.6xFinancials
CFR Compagnie Financière RichemontCHF 160.004.6%
+CHF 4.2b		16.9%PE26.7xConsumer Discretionary
SIKA SikaCHF 157.2014.5%
+CHF 3.2b		-19.6%PE24.2xMaterials
NESN NestléCHF 79.021.2%
+CHF 2.4b		-10.2%PE22.5xConsumer Staples
See more

Market Insights

Header cover image
A (virtual) reality check for VR, Web3 and Metaverse
Richard Bowman avatar
Richard Bowman
The Metaverse, NFTs, and Web3 all burst into the spotlight in 2021 and then faded away just as quickly. Welcome to part 3 of the three-part “What’s happening with…” series.
Continue reading
Is it time to revisit Cybersecurity and Cloud?

Latest News

ROP
CHF 320.00
Roche Holding
7D
0.9%
1Y
25.2%

Late Stage Pipeline And Diagnostics Expansion Will Transform Long Term Healthcare Leadership

Catalysts About Roche Holding Roche is a global healthcare company focused on pharmaceuticals and diagnostics across oncology, neurology, immunology, ophthalmology and cardiometabolic diseases. What are the underlying business or industry changes driving this perspective?
PGHN
CHF 949.20
Partners Group Holding
7D
9.5%
1Y
-10.3%

PGHN: Rebased Earnings Assumptions Will Support Future Confidence In Premium Pricing

Analysts have trimmed their price target for Partners Group Holding from about CHF1,252 to around CHF1,189, reflecting updated expectations for slightly lower revenue growth, profit margins and future P/E assumptions. Analyst Commentary Recent analyst reports offer a mix of optimism and caution on Partners Group Holding, with views split on how current fundamentals and expectations line up with the latest valuation and P/E assumptions.
ABBN
CHF 75.48
ABB
7D
5.4%
1Y
78.9%

ABBN: Elevated Future P/E Will Struggle Against Mixed Execution And Margin Risks

ABB's analyst price target has been revised higher to roughly CHF 55, up about CHF 2, as analysts factor in recent target hikes from UBS, RBC Capital and JPMorgan, along with updates to long term growth and P/E assumptions, partly offset by a fresh downgrade and a slightly lower profit margin outlook. Analyst Commentary Recent Street research on ABB presents a mixed picture, with several firms lifting price targets while at least one bearish analyst has moved to a more cautious stance.
BARN
CHF 1,085.00
Barry Callebaut
7D
-15.9%
1Y
43.1%

BARN: Future Multiple Expansion Will Rely On Volume Recovery Under New CEO Appointment

Analyst price targets for Barry Callebaut have been revised lower in recent research, with cuts of up to CHF 300 as analysts factor in softer volume trends, pressure on profit margins and a higher assumed P/E multiple in their updated models. Analyst Commentary Recent research on Barry Callebaut points to a more cautious tone, with several firms cutting price targets and shifting ratings lower as they reassess the company’s risk reward.
NESN
CHF 79.02
Nestlé
7D
1.2%
1Y
-10.2%
GALD
CHF 156.85
Galderma Group
7D
-1.3%
1Y
99.7%
SREN
CHF 131.55
Swiss Re
7D
-1.2%
1Y
-7.2%

SREN: Buybacks And Earnings Guidance Will Drive Future Re Rating Potential

Analysts have trimmed the Swiss Re price target by CHF 2 to reflect slightly adjusted fair value assumptions after recent target cuts to CHF 118 and CHF 145, as well as a downgrade from another firm. Analyst Commentary Recent research on Swiss Re has tilted more cautious on headline price targets, but there are still constructive signals you can pull out of the updates.
LONN
CHF 543.40
Lonza Group
7D
5.1%
1Y
0.8%
BEKN
CHF 393.00
Berner Kantonalbank
7D
-7.6%
1Y
58.1%
UBSG
CHF 34.45
UBS Group
7D
4.2%
1Y
49.8%

UBSG: Legal And Execution Risks Will Constrain Future Re Rating Potential

UBS Group's analyst price target has shifted slightly, with CHF level adjustments reflecting updated views on more modest revenue growth, a higher profit margin outlook, and recalibrated P/E expectations following recent target cuts and downgrades by several firms. Analyst Commentary Recent Street research on UBS Group points to a more cautious undertone, with several bearish analysts trimming price targets and, in one case, moving to a less favorable rating.
SIKA
CHF 157.20
Sika
7D
14.5%
1Y
-19.6%
LUKN
CHF 100.00
Luzerner Kantonalbank
7D
-6.7%
1Y
46.2%
NOVN
CHF 118.82
Novartis
7D
-1.5%
1Y
31.1%

NOVN: Dermatology And Immunology Pipeline Plus Dividend Will Shape Balanced Outlook

Analysts have slightly reduced their Novartis price target to CHF121.41 from CHF121.50. This change reflects updated assumptions that combine a somewhat lower revenue growth outlook with a modestly higher profit margin and a small adjustment to the future P/E multiple.
BCVN
CHF 120.90
Banque Cantonale Vaudoise
7D
-10.1%
1Y
22.2%
CFR
CHF 160.00
Compagnie Financière Richemont
7D
4.6%
1Y
16.9%
SCMN
CHF 650.50
Swisscom
7D
-1.6%
1Y
21.4%